Squarepoint’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.4M | Sell |
140,165
-61,665
| -31% | -$16.7M | 0.04% | 427 |
|
|
2025
Q4 | $50.6M | Buy |
201,830
+175,973
| +681% | +$46.7M | 0.05% | 399 |
|
|
2025
Q3 | $7.42M | Buy |
25,857
+3,133
| +14% | +$839K | 0.01% | 1232 |
|
|
2025
Q2 | $5.97M | Buy |
22,724
+19,707
| +653% | +$4.8M | 0.01% | 1348 |
|
|
2025
Q1 | $702K | Sell |
3,017
-8
| -0.3% | -$1.94K | ﹤0.01% | 2976 |
|
|
2024
Q4 | $694K | Sell |
3,025
-18,221
| -86% | -$4.18M | ﹤0.01% | 3424 |
|
|
2024
Q3 | $4.75M | Buy |
21,246
+10,608
| +100% | +$2.33M | 0.01% | 1452 |
|
|
2024
Q2 | $2.16M | Sell |
10,638
-80,039
| -88% | -$16.3M | ﹤0.01% | 1999 |
|
|
2024
Q1 | $19.8M | Buy |
90,677
+74,921
| +476% | +$16.5M | 0.03% | 617 |
|
|
2023
Q4 | $3.58M | Sell |
15,756
-23,723
| -60% | -$4.98M | 0.01% | 1611 |
|
|
2023
Q3 | $7.94M | Buy |
39,479
+35,527
| +899% | +$7.49M | 0.02% | 905 |
|
|
2023
Q2 | $819K | Buy |
+3,952
| New | +$767K | ﹤0.01% | 2316 |
|
|
2022
Q4 | – | Sell |
-34,440
| Closed | -$6.73M | – | 3435 |
|
|
2022
Q3 | $6.06M | Buy |
34,440
+32,945
| +2,204% | +$6.74M | 0.03% | 644 |
|
|
2022
Q2 | $301K | Sell |
1,495
-44,225
| -97% | -$9.43M | ﹤0.01% | 2288 |
|
|
2022
Q1 | $10.4M | Buy |
45,720
+42,556
| +1,345% | +$10M | 0.04% | 449 |
|
|
2021
Q4 | $854K | Sell |
3,164
-100,283
| -97% | -$24.8M | ﹤0.01% | 1795 |
|
|
2021
Q3 | $25M | Buy |
103,447
+97,505
| +1,641% | +$24.6M | 0.07% | 249 |
|
|
2021
Q2 | $1.41M | Sell |
5,942
-23,830
| -80% | -$5.43M | 0.01% | 1392 |
|
|
2021
Q1 | $6.52M | Buy |
29,772
+8,232
| +38% | +$1.65M | 0.04% | 521 |
|
|
2020
Q4 | $3.77M | Sell |
21,540
-49,607
| -70% | -$8.57M | 0.03% | 613 |
|
|
2020
Q3 | $11.5M | Sell |
71,147
-23,840
| -25% | -$3.78M | 0.16% | 156 |
|
|
2020
Q2 | $13.6M | Buy |
94,987
+48,951
| +106% | +$6.77M | 0.22% | 108 |
|
|
2020
Q1 | $5M | Sell |
46,036
-140,815
| -75% | -$20.3M | 0.13% | 202 |
|
|
2019
Q4 | $27.2M | Buy |
186,851
+149,373
| +399% | +$21.6M | 0.16% | 108 |
|
|
2019
Q3 | $5.41M | Buy |
37,478
+32,954
| +728% | +$4.81M | 0.05% | 454 |
|
|
2019
Q2 | $672K | Sell |
4,524
-68,796
| -94% | -$9.6M | 0.01% | 1494 |
|
|
2019
Q1 | $9.64M | Sell |
73,320
-168,365
| -70% | -$20.7M | 0.1% | 244 |
|
|
2018
Q4 | $26.2M | Buy |
241,685
+168,859
| +232% | +$22.6M | 0.31% | 53 |
|
|
2018
Q3 | $10.9M | Buy |
+72,826
| New | +$11.1M | 0.13% | 202 |
|
|
2018
Q2 | – | Sell |
-178,302
| Closed | -$24.8M | – | 1916 |
|
|
2018
Q1 | $24.8M | Buy |
178,302
+169,792
| +1,995% | +$24.9M | 0.39% | 48 |
|
|
2017
Q4 | $1.17M | Sell |
8,510
-27,503
| -76% | -$3.63M | 0.02% | 765 |
|
|
2017
Q3 | $4.67M | Buy |
36,013
+31,241
| +655% | +$4.17M | 0.09% | 287 |
|
|
2017
Q2 | $632K | Sell |
4,772
-44,844
| -90% | -$5.49M | 0.01% | 872 |
|
|
2017
Q1 | $6.12M | Buy |
49,616
+35,789
| +259% | +$4.24M | 0.17% | 142 |
|
|
2016
Q4 | $1.52M | Sell |
13,827
-5,179
| -27% | -$575K | 0.06% | 363 |
|
|
2016
Q3 | $2.25M | Sell |
19,006
-17,335
| -48% | -$2.04M | 0.15% | 163 |
|
|
2016
Q2 | $4.07M | Buy |
36,341
+18,949
| +109% | +$2.04M | 0.25% | 76 |
|
|
2016
Q1 | $1.75M | Buy |
17,392
+11,082
| +176% | +$1.06M | 0.14% | 210 |
|
|
2015
Q4 | $670K | Sell |
6,310
-8,487
| -57% | -$876K | 0.07% | 398 |
|
|
2015
Q3 | $1.38M | Buy |
14,797
+6,320
| +75% | +$654K | 0.34% | 83 |
|
|
2015
Q2 | $883K | Buy |
+8,477
| New | +$882K | 0.29% | 100 |
|
Other funds holding LH
VCM
VPM
Squarepoint's LH Position: Q1 2026 in Review
Squarepoint reduced its Labcorp (LH) stake by 31% in Q1 2026, selling an estimated $16.7M and leaving 140,165 shares worth $37.4M. The position accounts for 0.04% of the portfolio, ranked #427.
Squarepoint first reported a position in LH in Q2 2015 and has held it in 41 quarters since. The position peaked at $50.6M in Q4 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Squarepoint held 140,165 shares of Labcorp worth $37.4M as of Q1 2026.
- Squarepoint sold 61,665 Labcorp shares in Q1 2026, an estimated $16.7M.
- Labcorp made up 0.04% of Squarepoint's portfolio in Q1 2026, its #427 holding.
- Squarepoint first reported a position in Labcorp in Q2 2015 and has held it in 41 quarters since.
- Squarepoint's Labcorp position peaked at $50.6M in Q4 2025.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.